About Vanta Bioscience
Vanta Bioscience is a company based in Chennai (India) founded in 2010 was acquired by Aragen in November 2014. The company has 43 employees as of March 22, 2024. Vanta Bioscience offers products and services including Discovery Toxicology, Agro-chemicals and Chemical Safety, Biocompatibility Studies, Diet Formulation, and Batch Release Test. Vanta Bioscience operates in a competitive market with competitors including Gentronix, Tigermed, Shanghai Semero Biotechnology, Gubra and BioQual, among others.
- Headquarter Chennai, India
- Employees 43 as on 22 Mar, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Vanta Bioscience Ltd.
-
Annual Revenue
$229.89 K (USD)-79.8as on Mar 31, 2025
-
Net Profit
-$558.91 K (USD)-106.18as on Mar 31, 2025
-
EBITDA
-$498.16 K (USD)-419.5as on Mar 31, 2025
-
Latest Funding Round
- Investors
-
Employee Count
43
as on Mar 22, 2024
-
Acquired by
Aragen
(Nov 06, 2014)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Vanta Bioscience
Vanta Bioscience is a publicly listed company on the BSE with ticker symbol VANTABIO in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Vanta Bioscience
Vanta Bioscience offers a comprehensive portfolio of products and services, including Discovery Toxicology, Agro-chemicals and Chemical Safety, Biocompatibility Studies, Diet Formulation, and Batch Release Test.
Preclinical testing for drug safety and toxicity evaluation
Evaluation of safety for agrochemical products
Assessment of material compatibility for medical devices
Development of specialized diets for research studies
Testing for batch quality in pharmaceutical products
People of Vanta Bioscience
Unlock access to complete
Unlock access to complete
Funding Insights of Vanta Bioscience
Investors in Vanta Bioscience
Vanta Bioscience has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Aragen Life Sciences.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Aragen Life Sciences is engaged in contract research and manufacturing for pharmaceuticals.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Vanta Bioscience
Financial Statements - Vanta Bioscience
Vanta Bioscience Comparisons
Competitors of Vanta Bioscience
Vanta Bioscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Gentronix, Tigermed, Shanghai Semero Biotechnology, Gubra and BioQual, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
In-vitro and in-vivo genetic toxicology screening services are provided.
|
|
| domain | founded_year | HQ Location |
Drug development and preclinical services are provided by Tigermed.
|
|
| domain | founded_year | HQ Location |
Diversified preclinical services for brain-related disorders are provided.
|
|
| domain | founded_year | HQ Location |
Preclinical CRO services for NAFLD/NASH, diabetes, and obesity are provided.
|
|
| domain | founded_year | HQ Location |
Contract research on infectious disease models is conducted.
|
|
| domain | founded_year | HQ Location |
Preclinical services in immunology, regeneration, neuroscience, and histology are provided.
|
Frequently Asked Questions about Vanta Bioscience
Vanta Bioscience was founded in 2010.
Vanta Bioscience is headquartered in Chennai, India. It is registered at Chennai, Tamil Nadu, India.
As of Mar 22, 2024, the latest employee count at Vanta Bioscience is 43.
Annual revenue of Vanta Bioscience is $229.89K as on Mar 31, 2025.
Vanta Bioscience was founded in 2010 in Chennai, India. Preclinical contract research services, certified under GLP standards, are offered to pharmaceutical, biotech, medical device, cosmetics, and chemical industries. Toxicology studies, biocompatibility assessments, and diet formulation services are included. A state-of-the-art research facility is maintained in compliance with international guidelines for animal care and use, with relevant accreditations ensuring adherence to regulatory requirements.
Vanta Bioscience offers Discovery Toxicology, Agro-chemicals and Chemical Safety, Biocompatibility Studies, Diet Formulation, and Batch Release Test.
Yes, Vanta Bioscience is publicly traded on BSE under the ticker symbol VANTABIO.
Vanta Bioscience has 1 investor. Key investors include Aragen Life Sciences.
The ticker symbol of Vanta Bioscience is VANTABIO on BSE.